Our team is excited to announce that we’re moving into a an early stage research phase to determine whether the above specific therapeutic approach has the potential to correct OTC Deficiency in paediatric patients. The next few months will be focused on several experiments to demonstrate whether there is any merit to this idea of using maternal stem cells.